Atlas

FDA-Inspected Site

Nanjing Xingyin Pharmaceutical Group Co. Ltd.

3 FDA inspections are on record for Nanjing Xingyin Pharmaceutical Group Co. Ltd. in Nanjing, China.

483· Form 483 issued

Nanjing, China · Last updated August 15, 2026

Overview

  • 3 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-01-19.

At a glance

Inspections

3

Form 483s

3

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
15 Jan 2024 – 19 Jan 2024Human Drugs483On file
5 Nov 2018 – 9 Nov 2018Animal Drugs & Feeds483On file
28 Aug 2017 – 31 Aug 2017Human Drugs483On file

Investigators

FDA investigators tied to this site in the record.

Rajiv R Srivastava1 insp.
Amy N Chen1 insp.
Arsen Karapetyan1 insp.
Meisha R Sampson1 insp.

Full site report

Get the verbatim findings behind Nanjing Xingyin Pharmaceutical Group Co. Ltd.'s 3 Form 483s

The full inspection record, as Atlas holds it, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat